Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GMS Tenshi Holdings Pte. Limited
Singapore
- Ownership
- Private
- Development stage
- Other
01
Overview
GMS Tenshi Holdings is a Singapore-based joint venture between Tenshi Life Sciences Private Limited and GMS Holdings. It focuses on investments in the biosimilar space for emerging markets, notably licensing rights to biosimilars for adalimumab (Humira) and bevacizumab (Avastin) for these regions.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Monoclonal antibody
- Industry
- Biotech
02
Partnerships
Oncobiologics, Inc.Tenshi Life Sciences Private LimitedGMS Holdings
Beyond the preview
Go deeper on GMS Tenshi Holdings Pte. Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GMS Tenshi Holdings Pte. Limited.